08:00~09:00 |
Registration
|
09:00~09:30 |
Opening Ceremony
|
PL 1 : Continued success of Xcopri development: NDA, subsequent development and commercialization
|
09:30~10:00 |
Plenary Lecture 1 |
Chair : In-Jin Jang |
09:30~10:00 |
Continued success of XCOPRI® development: NDA, subsequent development and commercialization
|
Jeong-Woo Cho |
SK Biopharmaceuticals Co., Ltd. |
10:00~10:30 |
Coffee Break
|
PS 1 Talkshow: Creating global success of drug development in extremely competitive environment
|
10:30~12:00 |
Plenary Session1 |
Chair : Hanlim Moon |
10:30~12:00 |
PS 1 Talkshow: Creating global success of drug development in extremely competitive environment
|
- - |
- |
10:30~12:00 |
┗━ Special Panel : Byoungjun Bae(KoNECT), Myungjin Jung(Financial News) / Panel : Healthcare Discovery - Youngki Shin(Abion), Branden Ryu(BIORCHESTRA)
|
10:30~12:00 |
┗━ Panel : Clinical Development - Seung-Jae Baek(Hanmi Pharm Co. Ltd) , Se-Woong Oh(Yuhan Corporation) / Commercial - Geun-Seog Song(HK inno.N Corp.), Hyeokjae Lee(Celltrion)
|
12:00~13:30 |
Lunch
|
S1 : Patient-Centric Drug Development & S4 : Drug Delivery to the Target Tissue
|
13:30~15:00 |
S1: Patient-Centric Drug Development |
Chair : BG Rhee, Yu-Kyeong Hwang |
13:30~13:50 |
Patient-Centric CAR-T Development
|
Dong-Hyuk Jeon |
CUROCELL |
13:50~14:10 |
Symptom-specific control of movement disorders by CaV3.2 ASO
|
Daesoo Kim |
KAIST |
14:10~14:30 |
Genetic Medicine with Non-viral Delivery Technology
|
Yoonchul Shin |
GenEdit |
14:30~14:50 |
Open Discussion
|
14:50~15:00 |
Q&A
|
15:00~15:30 |
Coffee Break
|
15:30~17:00 |
S4: Drug Delivery to the Target Tissue |
Chair : Jinsan Yoo, Jong-Seo Lee |
15:30~15:50 |
Overcoming the Blood-Brain Barrier for RNA therapeutics
|
Mi Jung Lim |
BIORCHESTRA Co., Ltd. |
15:50~16:10 |
Brain Somatic Mutations as RNA Therapeutic Targets in Neurological Disorders
|
Jeong-Ho Lee |
SoVarGen/KAIST |
16:10~16:30 |
BBB Shuttle by Aptamer Technology
|
Daekyun Lee |
Aptamer Sciences |
16:30~17:00 |
New era of mRNA Therapeutics
|
Hyun-Bae Jie |
Levatio Therapeutics |
17:00~17:30 |
Open Discussion
|
S2 : Creating Comprehensive Drug Development Plan: Strategic Planning through the Product Lifecycle & S5 : Creating Comprehensive Drug Development Plan
|
13:30~15:00 |
S2 : Creating Comprehensive Drug Development Plan: Strategic Planning through the Product Lifecycle |
Chair : Mi-Young Bahng, Jungshin Park |
13:30~14:00 |
Begin with end in mind: Target product profile and clinical development plan
|
Nari Yun |
GI Innovation |
14:00~14:30 |
Orphan Drug and Expedited Drug Development Programs in US/EU
|
Hye Jin Choi |
IQVIA |
14:30~15:00 |
Global & Market Expansion of K-CAB
|
Eunji Kim |
HK inno.N |
15:00~15:30 |
Coffee Break
|
15:30~17:00 |
S5 : Creating Comprehensive Drug Development Plan: Strategic Planning through Multifunctional Integration |
Chair : Myunghoon Kim, Sora Lee |
15:30~15:50 |
Marketing principles applied to clinical development
|
Seungwon Jeong |
Hanall Bio |
15:50~16:10 |
Clinical Trial Design for Regulatory and Commercial Success
|
Miyoung Kim |
LG Chemical Life Sciences |
16:10~16:30 |
Biostatistical Validation of Protocol for Clinical and Commercial Success
|
Sang Joon Lee |
Celltrion |
16:30~16:45 |
How to Incorporate Market Access Strategy to Clinical Trials
|
Yuri Lee |
AMGEN |
16:45~17:00 |
Q&A and Pannel Discussion
|
S3 : Understanding Market and Investment Theory & S6: Practical Investment Guide based on Real Cases
|
13:30~15:00 |
S3 : Understanding Market and Investment Theory |
Chair : Myungkee Kim |
13:30~13:50 |
Global/Korean Life Science Investment Market Trend
|
Min Sik Shin |
KB Investment |
13:50~14:10 |
Selecting the Right Biotech Company to Invest
|
Aleum Lee |
IMM Investment |
14:10~14:30 |
Opportunities Created by a Bear Market
|
Ted Moon |
RM Global Partners |
14:30~14:50 |
Healthcare Company IPO Trends & Technology Assessment Listing Track Strategies
|
Wonje Kim |
Samsung Securities Co., Ltd |
14:50~15:00 |
Q&A
|
15:30~17:00 |
S6 : Practical Investment Guide based on Real Cases |
Chair : Minsik Park |
15:30~16:00 |
IPO by Technology Assessment Listing
|
Jung-Sun Yum |
CHA Vaccine Institute |
16:00~16:25 |
Listing Experiences in the KONEX & KOSDAQ - Genome & Company
|
Youngjin Seo |
Genome & Company |
16:25~16:50 |
IPO by Special Purpose Acquisition Company (SPAC)
|
Kisub Lee |
Kainos Medicine |
16:50~17:00 |
Q&A
|